Transcat (NASDAQ:TRNS) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Transcat (NASDAQ:TRNS) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $124.00 price target on the scientific and technical instruments company’s stock.

Separately, TheStreet upgraded Transcat from a c+ rating to a b rating in a report on Wednesday, January 31st.

Transcat Stock Performance

TRNS opened at $108.55 on Tuesday. The stock has a market cap of $958.50 million, a P/E ratio of 83.50 and a beta of 0.59. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The stock’s 50 day simple moving average is $108.78 and its 200 day simple moving average is $101.86. Transcat has a 1-year low of $74.89 and a 1-year high of $115.41.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $65.17 million for the quarter, compared to analysts’ expectations of $63.36 million. Transcat had a return on equity of 9.32% and a net margin of 4.16%. As a group, equities analysts anticipate that Transcat will post 1.36 EPS for the current fiscal year.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 2,373 shares of the company’s stock in a transaction that occurred on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total value of $264,423.39. Following the sale, the chief executive officer now owns 103,688 shares of the company’s stock, valued at approximately $11,553,953.84. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Transcat news, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now owns 103,688 shares of the company’s stock, valued at approximately $11,553,953.84. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Charles P. Hadeed sold 700 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the transaction, the director now directly owns 22,678 shares in the company, valued at approximately $2,562,614. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,073 shares of company stock valued at $900,023. 4.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. US Bancorp DE lifted its stake in shares of Transcat by 137.9% during the 1st quarter. US Bancorp DE now owns 345 shares of the scientific and technical instruments company’s stock worth $28,000 after purchasing an additional 200 shares during the period. BNP Paribas Arbitrage SA raised its position in shares of Transcat by 162.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,626 shares of the scientific and technical instruments company’s stock worth $92,000 after buying an additional 1,006 shares during the period. Barclays PLC raised its position in shares of Transcat by 533.1% in the 4th quarter. Barclays PLC now owns 1,912 shares of the scientific and technical instruments company’s stock worth $135,000 after buying an additional 1,610 shares during the period. Tower Research Capital LLC TRC raised its position in shares of Transcat by 345.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,234 shares of the scientific and technical instruments company’s stock worth $135,000 after buying an additional 957 shares during the period. Finally, Legal & General Group Plc raised its position in shares of Transcat by 219.9% in the 4th quarter. Legal & General Group Plc now owns 2,703 shares of the scientific and technical instruments company’s stock worth $192,000 after buying an additional 1,858 shares during the period. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.